Mechanisms of "immune paralysis" caused by filoviruses
Mechanisms of "immune paralysis" caused by filoviruses
批准号:
8811915
负责人:
Alexander Bukreyev
金额:
$36.45万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Antigen-Presenting CellsAntigensApoptosisApoptoticAreaBlood donorCD8B1 geneCell MaturationCellsCentral AfricaCessation of lifeDataDendritic CellsDisabled PersonsDisease OutbreaksEbola virusEndothelial CellsFamily memberFiloviridaeFilovirusFrankfurt-Marburg Syndrome VirusGene Expression ProfileHumanICAM1 geneImmuneImmune systemImmunologyIndividualInfectionInterferon Type IInterferonsInvestigationKnowledgeLaboratoriesLeadLigandsLinkLymphopeniaMediatingMethodsMissionMolecular ModelsMolecular VirologyMutateMutationNatural ImmunityParalysedPathway interactionsPoint MutationProteinsPublic HealthRecombinantsResearchResearch PersonnelRoleSignal TransductionSystemT cell responseT-Cell ActivationT-Cell ProliferationT-LymphocyteTNFSF10 geneTestingTumor Necrosis Factor-alphaUniversitiesUp-RegulationVaccinesViralViral Hemorrhagic FeversViral ProteinsVirusVirus DiseasesWorkadaptive immunitybiosafety level 4 facilitycell typechemokinecytokinedeep sequencingexperiencehuman diseaselymph nodesmacrophagemembermolecular modelingmortalitymutantnonhuman primatepathogenresearch studyresponsetherapeutic development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Infections with filoviruses Ebola (EBOV) and Marburg (MARV), lead to the "immune paralysis" characterized by a deficient T cell response and lymphopenia, despite the lack of infection of T cells, and a severe hemorrhagic fever with up to 80% mortality. Over the past decade, researchers identified multiple mechanisms of type I interferon (IFN-I) antagonism mediated by filovirus proteins. However, the mechanisms of the rapid and deleterious disabling of the adaptive immune response by filoviruses remain unknown.
Dendritic cells (DC), which are the professional antigen-presenting cells, are believed to be readily infected, but do not undergo normal maturation. Our preliminary data have demonstrated the strong connection between IFN-I antagonism caused by EBOV and the lack of DC maturation. The central hypothesis of the proposal is that the unusually strong and redundant antagonism of the IFN-I response mediated by filovirus proteins and by multiple mechanisms, blocks maturation of DC, resulting in the deficient and/or aberrant stimulation of T cells. The hypothesis will be tested by pursuing three specific aims: 1) Determine the role of IFN-antagonizing domains and IFN-I signaling in the maturation of DC and in the activation, proliferation and apoptosis of T cells; 2) Determine the role of soluble factors secreted by the infected DC and specific inhibitory and pro-apoptotic molecules in the activation, proliferation and apoptosis of T cells; 3) Determine whether the suppression of T cell activation and proliferation or T cell apoptosis during filovirus infection can be reversed by induction of DC maturation. The project will involve the infection of DC derived from donor blood with a recombinant EBOV, its mutants with the IFN-I antagonizing domains disabled, or MARV; stimulation of primary human CD4+ and CD8+ T cells; characterization of the effects of filovirus infection and IFN-antagonizing domains on transcriptomes of infected DC and stimulated T cells by deep sequencing; blockade of IFN-I signaling and immuno-suppressive and pro-apoptotic pathways; and attempts to rescue maturation of infected DC with cytokine cocktails. Together, these experiments represent a broad, integrated approach to investigate the mechanisms of disabling the adaptive immune response by filoviruses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus
-
批准号:10394314
-
项目类别:
-
资助金额:$252.83万
-
财政年份:2021
-
负责人:Alexander Bukreyev
-
依托单位:
Core B: Biosafety Level 4 Core
-
批准号:10394316
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2021
-
负责人:Alexander Bukreyev
-
依托单位:
Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease
-
批准号:10602491
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2021
-
负责人:Alexander Bukreyev
-
依托单位:
Core A: Administrative Core
-
批准号:10188755
-
项目类别:
-
资助金额:$8.06万
-
财政年份:2021
-
负责人:Alexander Bukreyev
-
依托单位:
Core A: Administrative Core
-
批准号:10602483
-
项目类别:
-
资助金额:$8.31万
-
财政年份:2021
-
负责人:Alexander Bukreyev
-
依托单位:
Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus
-
批准号:10602482
-
项目类别:
-
资助金额:$221.31万
-
财政年份:2021
-
负责人:Alexander Bukreyev
-
依托单位:
Core B: Biosafety Level 4 Core
-
批准号:10188756
-
项目类别:
-
资助金额:$21.56万
-
财政年份:2021
-
负责人:Alexander Bukreyev
-
依托单位:
Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease
-
批准号:10188759
-
项目类别:
-
资助金额:$42.55万
-
财政年份:2021
-
负责人:Alexander Bukreyev
-
依托单位:
Core A: Administrative Core
-
批准号:10394315
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2021
-
负责人:Alexander Bukreyev
-
依托单位:
Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease
-
批准号:10394319
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2021
-
负责人:Alexander Bukreyev
-
依托单位:
Core B: Biosafety Level 4 Core
-
批准号:10602485
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2021
-
负责人:Alexander Bukreyev
-
依托单位:
Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus
-
批准号:10188754
-
项目类别:
-
资助金额:$225.87万
-
财政年份:2021
-
负责人:Alexander Bukreyev
-
依托单位:
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine
-
批准号:10512752
-
项目类别:
-
资助金额:$76.7万
-
财政年份:2018
-
负责人:Alexander Bukreyev
-
依托单位:
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine
-
批准号:10291418
-
项目类别:
-
资助金额:$75.67万
-
财政年份:2018
-
负责人:Alexander Bukreyev
-
依托单位:
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine
-
批准号:10053317
-
项目类别:
-
资助金额:$75.89万
-
财政年份:2018
-
负责人:Alexander Bukreyev
-
依托单位:
BIOSAFETY LEVEL 4 CORE
-
批准号:8642744
-
项目类别:
-
资助金额:$51.74万
-
财政年份:2014
-
负责人:Alexander Bukreyev
-
依托单位:
Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses
-
批准号:8578747
-
项目类别:
-
资助金额:$55.45万
-
财政年份:2013
-
负责人:Alexander Bukreyev
-
依托单位:
Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses
-
批准号:8850798
-
项目类别:
-
资助金额:$74.05万
-
财政年份:2013
-
负责人:Alexander Bukreyev
-
依托单位:
Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses
-
批准号:8665378
-
项目类别:
-
资助金额:$73.68万
-
财政年份:2013
-
负责人:Alexander Bukreyev
-
依托单位:
Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses
-
批准号:9269983
-
项目类别:
-
资助金额:$74.05万
-
财政年份:2013
-
负责人:Alexander Bukreyev
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: